- Musidin Tablet 2mg is primarily indicated in conditions like Breast cancer, Breast cancer (unlicensed indication), Dysfunctional uterine bleeding, Gonadal dysgenesis, Heriditary haemorrhagic telangiectasia, Hormone replacement for menopausal symptoms, Hormone replacement therapy, Menopausal symptoms, oestrogen deficiency, Osteoporosis prophylaxis, Pre-ovulatory mucus, Prostatic cancer, and can also be given in adjunctive therapy as an alternative drug of choice in Acne, Contraception, Endometriosis, Hirsutism, Menstruation disorders.
- The severe or irreversible adverse effects of Musidin Tablet 2mg, which give rise to further complications include Impotence, Loss of libido, Gynacomastia, Chloasma, MI.Musidin Tablet 2mg produces potentially life-threatening effects which include Pulmonary embolism, Hypertension, Venous thromboembolism, Endometrial carcinoma, Endometrial hyperplasia, Cerebral thrombosis, Gall bladder disease, Liver tumors, Breast carcinoma, Venous thromboembolism, Coronary thrombosis. which are responsible for the discontinuation of Musidin Tablet 2mg therapy. The signs and symptoms that are produced after the acute overdosage of Musidin Tablet 2mg include Nausea, vomiting, Coronary thrombosis, Uterine withdrawal bleeding. The symptomatic adverse reactions produced by Musidin Tablet 2mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, vomiting, Weight gain, Fluid retention, Intermenstrual bleeding or spotting, Chloasma, Cholestatic Jaundice, Vaginal candidiasis, dizziness.
- High doses of Musidin Tablet 2mg used in treatment of malignant disease should be used with caution in patients with cerebrovascular disorder, coronary artery disease or venous thromboembolism. It should be used with caution in children, because premature closure of epiphysis may occur resulting in inhibited linear growth and small stature.